These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 20187154

  • 1. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
    Kao AH, Navratil JS, Ruffing MJ, Liu CC, Hawkins D, McKinnon KM, Danchenko N, Ahearn JM, Manzi S.
    Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
    [Abstract] [Full Text] [Related]

  • 2. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S, Rairie JE, Carpenter AB, Kelly RH, Jagarlapudi SP, Sereika SM, Medsger TA, Ramsey-Goldman R.
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J, An L, Zhang Z.
    Clin Exp Rheumatol; 2014 Jul; 32(1):48-53. PubMed ID: 23981509
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus.
    Yang DH, Chang DM, Lai JH, Lin FH, Chen CH.
    Rheumatology (Oxford); 2009 Sep; 48(9):1083-7. PubMed ID: 19553377
    [Abstract] [Full Text] [Related]

  • 5. Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus.
    Liu CC, Kao AH, Hawkins DM, Manzi S, Sattar A, Wilson N, Ahearn JM.
    Clin Transl Sci; 2009 Aug; 2(4):300-8. PubMed ID: 20161444
    [Abstract] [Full Text] [Related]

  • 6. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
    Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM.
    Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
    [Abstract] [Full Text] [Related]

  • 7. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
    Lood C, Eriksson S, Gullstrand B, Jönsen A, Sturfelt G, Truedsson L, Bengtsson AA.
    Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
    [Abstract] [Full Text] [Related]

  • 8. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Singh V, Mahoney JA, Petri M.
    J Rheumatol; 2008 Oct; 35(10):1989-93. PubMed ID: 18709693
    [Abstract] [Full Text] [Related]

  • 9. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
    Ganguly S, Majumder S, Kumar S, Gupta R, Muhammed H, Shobha V, Aggarwal A, Misra R.
    Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
    [Abstract] [Full Text] [Related]

  • 10. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G, Makinde VA, Vergani D, Isenberg DA.
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [Abstract] [Full Text] [Related]

  • 11. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Hammond A, Rudge AC, Loizou S, Bowcock SJ, Walport MJ.
    Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783
    [Abstract] [Full Text] [Related]

  • 12. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
    Mora C, Medina-Rosas J, Santos AM, Jaimes DA, Arbeláez AM, Romero C, Cortes A, Londono J.
    J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
    [Abstract] [Full Text] [Related]

  • 13. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, Nilson SE, Krishnaswami S, King DE, Kao AH, Ahearn JM.
    Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
    [Abstract] [Full Text] [Related]

  • 14. Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE.
    Merrill JT, Petri MA, Buyon J, Ramsey-Goldman R, Kalunian K, Putterman C, Conklin J, Furie RA, Dervieux T.
    Lupus Sci Med; 2018 Nov; 5(1):e000263. PubMed ID: 29868177
    [Abstract] [Full Text] [Related]

  • 15. Platelet C4d is highly specific for systemic lupus erythematosus.
    Navratil JS, Manzi S, Kao AH, Krishnaswami S, Liu CC, Ruffing MJ, Shaw PS, Nilson AC, Dryden ER, Johnson JJ, Ahearn JM.
    Arthritis Rheum; 2006 Feb; 54(2):670-4. PubMed ID: 16447243
    [Abstract] [Full Text] [Related]

  • 16. Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus.
    Röther E, Lang B, Coldewey R, Hartung K, Peter HH.
    Clin Rheumatol; 1993 Mar; 12(1):31-5. PubMed ID: 8467609
    [Abstract] [Full Text] [Related]

  • 17. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
    Freysdottir J, Sigfusson A.
    J Immunol Methods; 1991 Aug 28; 142(1):45-52. PubMed ID: 1833467
    [Abstract] [Full Text] [Related]

  • 18. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
    Kalunian KC, Chatham WW, Massarotti EM, Reyes-Thomas J, Harris C, Furie RA, Chitkara P, Putterman C, Gross RL, Somers EC, Kirou KA, Ramsey-Goldman R, Hsieh C, Buyon JP, Dervieux T, Weinstein A.
    Arthritis Rheum; 2012 Dec 28; 64(12):4040-7. PubMed ID: 22932861
    [Abstract] [Full Text] [Related]

  • 19. Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus.
    Martin M, Smoląg KI, Björk A, Gullstrand B, Okrój M, Leffler J, Jönsen A, Bengtsson AA, Blom AM.
    Arthritis Res Ther; 2017 Dec 06; 19(1):266. PubMed ID: 29208014
    [Abstract] [Full Text] [Related]

  • 20. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA, Senaldi G, Jawad AS, Berry H, Vergani D.
    Ann Rheum Dis; 1989 Apr 06; 48(4):302-6. PubMed ID: 2785367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.